Correction to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
Andrea Ghelli Luserna Di Rorà, Martina Ghetti, Lorenzo Ledda, Anna Ferrari, Matteo Bocconcelli, Antonella Padella, Roberta Napolitano, Maria Chiara Fontana, Chiara Liverani, Enrica Imbrogno, Maria Teresa Bochicchio, Matteo Paganelli, Valentina Robustelli, Seydou Sanogo
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCircular RNAs in diseases
Correction to **: ** Cell Biol Toxicol (2023) 39:795–811
10.1007/s10565-021-09640-x
The original version of this article unfortunately contained an error in the funding section.
Currently the text regarding the Funding is "The study was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, investigator grant ref. 19226) and by ERA-Per-Med (reference number: ERAPERMED2018-275)". The corrected statement is as follows. "The study was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, investigator grant ref. 23810) and by ERA-Per-Med (reference number: ERAPERMED2018-275)".